PsychoGenics signs drug discovery agreement with Cephalon
PsychoGenics and Cephalon expect to jointly identify drug candidates suitable for clinical development. If Cephalon develops clinical candidates, PsychoGenics will receive milestone payments as well as royalties. If
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.